The spectrum of ocular involvement in systemic lupus erythematosus in a tertiary eye care center in Nepal
- PMID: 22106910
- DOI: 10.3109/09273948.2011.610023
The spectrum of ocular involvement in systemic lupus erythematosus in a tertiary eye care center in Nepal
Abstract
Purpose: Manifestations of Systemic lupus erythematosus are protean and the eye can get affected in more than a third of the cases. This study was conducted to evaluate the spectrum of ocular manifestation among Nepalese patients diagnosed with Systemic lupus erythematosus.
Methods: In this hospital based cross-sectional study, 91 established cases of Systemic lupus erythematosus were enrolled from January 2008 to June 2009 AD. Patient particulars including age, sex, duration, systemic involvement, laboratory findings and treatment history were noted. Detailed ophthalmological examination was carried.
Results: Out of 91 patients, 94.5% were females and 5.5% were males. Female/Male ratio was 17:1. Mean age of the patients was 26.59 ± 10.33 years. Ocular involvement was present in 47.3% (43) of the patients, the commonest manifestation being dry eye (39.5%) followed by lupus retinopathy (21%) and drug induced ocular complications (21%).
Conclusions: Ocular manifestations in Systemic lupus erythematosus are not uncommon.
Similar articles
-
[Neurological disorders in systemic lupus erythematosus patients].Pol Merkur Lekarski. 2009 Jan;26(151):43-8. Pol Merkur Lekarski. 2009. PMID: 19391506 Polish.
-
Ocular manifestations of systemic lupus erythematosus in children.Saudi Med J. 2003 Sep;24(9):964-6. Saudi Med J. 2003. PMID: 12973478
-
Cognitive impairment in systemic lupus erythematosus and neuropsychiatric systemic lupus erythematosus: a population-based neuropsychological study.J Clin Exp Neuropsychol. 2003 Feb;25(1):145-51. doi: 10.1076/jcen.25.1.145.13621. J Clin Exp Neuropsychol. 2003. PMID: 12607179
-
Systemic lupus erythematosus: demographics, prognosis, and outcome.J Rheumatol Suppl. 1997 May;48:67-71. J Rheumatol Suppl. 1997. PMID: 9150122 Review.
-
Medical therapy for systemic lupus erythematosus.J Miss State Med Assoc. 2011 Feb;52(2):39-43. J Miss State Med Assoc. 2011. PMID: 21387869 Review.
Cited by
-
Ocular fundus changes and association with systemic conditions in systemic lupus erythematosus.Front Immunol. 2024 Jul 18;15:1395609. doi: 10.3389/fimmu.2024.1395609. eCollection 2024. Front Immunol. 2024. PMID: 39091490 Free PMC article. Review.
-
Unveiling Ocular Manifestations in Systemic Lupus Erythematosus.J Clin Med. 2024 Feb 12;13(4):1047. doi: 10.3390/jcm13041047. J Clin Med. 2024. PMID: 38398361 Free PMC article. Review.
-
Scleral changes in systemic lupus erythematosus patients using swept source optical coherence tomography.Front Immunol. 2023 Nov 2;14:1278893. doi: 10.3389/fimmu.2023.1278893. eCollection 2023. Front Immunol. 2023. PMID: 38022606 Free PMC article.
-
Posterior segment involvement in systemic lupus erythematosus - A series from South India.Indian J Ophthalmol. 2023 May;71(5):1986-1993. doi: 10.4103/ijo.IJO_1705_22. Indian J Ophthalmol. 2023. PMID: 37203070 Free PMC article.
-
Systemic Lupus Erythematosus and Risk of Dry Eye Disease and Corneal Surface Damage: A Population-Based Cohort Study.Int J Environ Res Public Health. 2023 Feb 21;20(5):3776. doi: 10.3390/ijerph20053776. Int J Environ Res Public Health. 2023. PMID: 36900786 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
